Ser863

Site Information
NPSSSQNsQNFATyk SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 455806

In vivo Characterization
Methods used to characterize site in vivo:	[32P] bio-synthetic labeling ( 3 ) , mass spectrometry ( 1 ) , mutation of modification site ( 3 ) , phospho-antibody ( 2 , 3 ) , phosphoamino acid analysis ( 3 ) , phosphopeptide mapping ( 3 ) , western blotting ( 2 )
Relevant cell line - cell type - tissue:	'brain, hippocampus' ( 2 ) , 'neuron, cortical'-brain ( 3 ) , 293 (epithelial) ( 3 ) , brain ( 1 )

References
1	Guo A (2007) CST Curation Set: 2239; Year: 2007; Biosample/Treatment: tissue, brain/ischemia 20'; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]Q Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) ATM/ATR Substrate Antibody Cat#: 2851 Curated Info
2	Zhu Y, et al. (2005) Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 46, 905-16 15953419 Curated Info
3	McDonald BJ, Chung HJ, Huganir RL (2001) Identification of protein kinase C phosphorylation sites within the AMPA receptor GluR2 subunit. Neuropharmacology 41, 672-9 11640921 Curated Info